This trial is evaluating whether Treatment will improve 1 primary outcome and 3 secondary outcomes in patients with Malignancies. Measurement will happen over the course of 6 months.
This trial requires 72 total participants across 6 different treatment groups
This trial involves 6 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"About 2 million elderly people in the United States are diagnosed with airflow obstruction, chronic every year. The leading cause of chronic airflow obstruction is cigarette smoking, but other risk factors such as asthma, COPD, and a family history of chronic airflow obstruction are common. The clinical relevance of airflow obstruction, chronic is immense." - Anonymous Online Contributor
"There is an association between parallel airflow obstruction and air-flow-mechanical characteristics in asthma and chronic airflow obstruction. Asthmatics with the parallel airflow obstruction symptom-category may be at risk for airflow-mechanical abnormalities." - Anonymous Online Contributor
"The use of the pulmonary function tests may be helpful in the evaluation of patients with airflow obstruction diagnosed by chest radiographs. Follow-up monitoring of pulmonary function tests is important when there is a decrease in pulmonary functions." - Anonymous Online Contributor
"Most chronic airflow obstruction is managed primarily with non-pharmacological therapies such as inhalation of corticosteroids and other agents, however, pharmacological therapies are more common. More randomized controlled trials are needed to define optimal therapy." - Anonymous Online Contributor
"The presence of wheezing or nocturnal crackles is very suggestive of bronchial asthma but rarely presents in isolation and therefore, the role of the physical examination remains significant in the diagnostic process. A comprehensive history is required with an emphasis on possible exposures to allergens and smoking in the current and/or previous workplace and on respiratory symptoms such as wheezing and/or night or daytime crackles and possible cough induced by exertion, medication usage and/or fever." - Anonymous Online Contributor
"Airflow obstruction, chronic is a disease of respiratory system that is characterized by reduced spirometric parameters. Long-term airflow obstruction is closely correlated with decreased life expectancy and mortality. The diagnosis and the management of airflow obstruction, chronic are the subject of on-going research." - Anonymous Online Contributor
"There have been few recent developments in the overall management of patients with emphysema, and in the recent past, research has only been concerned with the effectiveness of inhaled corticosteroids and, therefore, patients with an insufficient response to inhaled corticosteroids may be candidates for an add-on to an optimal pulmonary rehabilitation." - Anonymous Online Contributor
"The data do not show that any type of treatment for chronic obstructive pulmonary disease, including bronchodilators, oxygen therapy, and the use of inhalers, had any significant impact on outcomes with respect to both health status and health-related quality of life." - Anonymous Online Contributor
"In a recent study, findings support evidence that asthma is related to chronic lower airway obstruction, which leads to repeated respiratory infections and, in turn, to chronic lung disease." - Anonymous Online Contributor
"There have not been any new methods developed to treat airflow obstruction. There have been trials with new medicines such as theophylline, the statins, and beta-2 stimulating agonists. The most common treatment is a change of medications and some of the patients show that they can have a good improvement. Currently, there are still no known benefits with any of these treatments for airflow obstruction, chronic that can be done in a clinic. It seems like the new medicines for chronic may take a long time until they are developed and accepted. The only way to find out the benefits of any treatment is with an intervention." - Anonymous Online Contributor
"The majority of published trials in this area failed to obtain institutional review board approval before starting enrollment. The number of published trials is still insufficient and many published trials are too small." - Anonymous Online Contributor
"Chronic bronchitis and emphysema are the 2 major causes of airflow obstruction in COPD. The two conditions are usually associated with pulmonary dysfunction, which might partly explain the high comorbidity of COPD with asthma in a large Caucasian population. Further studies are needed to determine whether other causes of chronic airflow obstruction exist, even in the COPD population." - Anonymous Online Contributor